Zeng, Linsheng, Hou, Jingjing, Ge, Cuihong, Li, Yanjun, Gao, Jianhua, Zhang, Congcong, Huang, Peiying, Du, Jiayu, Mo, Zhizhun, Liu, Yuxiang, and Zeng, Zhongyi
Objective: This study aimed to evaluate the clinical therapeutic efficacy of anti-snake venom serum blockade in treating local tissue necrosis caused by Chinese cobra (Naja atra) bites. Methods: Patients bitten by a Chinese cobra (Naja atra) (n = 50) that met the inclusion criteria were randomly divided into two groups: the experimental group (n = 25) and the control group (n = 25). The experimental group received regular as well as anti-snake venom serum blocking treatment, whereas regular treatment plus chymotrypsin blocking therapy was given to the control group. The necrotic volumes around snake wounds in these groups were detected on the first, third and seventh days. On the third day of treatment, some local tissues in the wounds were randomly selected for pathological biopsy, and the necrosis volume of the local tissue was observed. Furthermore, the amount of time required for wound healing was recorded. Results: On the third and seventh days post-treatment, the necrotic volume of the wound of the experimental group was much smaller than that of the control group, and the experimental group's wound healing time was shorter than that of the control group (all p < 0.05). Moreover, the pathological biopsies taken from the control group showed nuclear pyknosis, fragmentation, sparse nuclear density, and blurred edges, and the degree of necrosis was much higher than that of the experimental group. Conclusions: Anti-snake venom blocking therapy is a new and improved therapy with good clinical effect on local tissue necrosis caused by Chinese cobra bites; moreover, it is superior to conventional chymotrypsin blocking therapy in the treatment of cobra bites. It can better neutralize and prevent the spread of the toxin, reduce tissue necrosis, and shorten the course of the disease by promoting healing of the wound. Furthermore, this treatment plan is also applicable to wound necrosis caused by other snake toxins, such as tissue necrosis caused by elapidae and viper families. Clinical Trial Registration: This trial is registered in the Chinese Clinical Trial Registry, a primary registry of International Clinical Trial Registry Platform, World Health Organization (Registration No. ChiCTR2200059070; trial URL:http://www.chictr.org.cn/edit.aspx?pid=134353&htm=4). Author summary: Chinese cobra bites often cause local tissue necrosis and lead to physical disability, which is the difficulty of treatment. Considering that the cytotoxin in cobra is the main pathogenic factor causing local tissue necrosis, we proposed injecting anti-snake venom locally to increase its concentration in the wound, so as to neutralize the cytolytic activity of snake venom. In order to verify the clinical efficacy of the therapy, a randomized controlled trial were conducted: the experimental group was treated with anti-snake venom blocking therapy, while the control group was treated with chymotrypsin blocking therapy. The clinical efficacy was evaluated by comparing the local wound necrosis, wound healing time, etc. as the indicators. Then, the results showed that the experimental group had smaller wound necrosis area and also much shorter healing time than the control group, which clearly indicated that the local blocking treatment with anti-snake venom serum has much better clinical efficacy. Meanwhile, theoretically, the anti-snake venom blocking therapy is also suitable for the treatment against other snake bites. So, in future we expect to conduct more clinical studies on this, which will provide information on new treatments with much better clinical efficacy for patients. [ABSTRACT FROM AUTHOR]